- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02617420
Monitoring Adherence Using Mobile Technology
September 14, 2016 updated by: University of Colorado, Denver
This study plans to learn more about how children use their asthma medicines.
The investigators would like to see if special electronic monitoring devices that connect to smartphones and computers can help children to better manage their asthma
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
25
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Study subjects would be drawn from the list of high risk asthma patients and by pre-clinic chart review done by study investigator.
Description
Inclusion Criteria:
- age 6-17 years and their parents
- either 2 emergency department visits/prednisone bursts in the last 12 months or at least 1 asthma related hospitalization in the last 12 months
- requiring daily controller therapy with either inhaled corticosteroids or combination corticosteroids/long acting beta agonist (LABA).
- Patients using metered dose inhaler therapy would be eligible. Patients may also be on leukotriene antagonists,
- Must be made aware that they will have to read and accept to the terms of the User Agreement prior to enrollment in the study. If they do not agree they will not be able to continue participation. The User agreement will be read agreed to electronically when they begin using the device, however a paper version will be provided at the time of consent upon request.
Exclusion Criteria:
- Primary language other than English or Spanish
- Presence of other significant chronic lung disease including cystic fibrosis, interstitial lung disease, tracheostomy status.
- Patients using diskus therapy.
- Patients only on leukotriene antagonists.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Intervention
All patients will be enrolled in one arm.
These patients will have monitoring devices placed on their asthma controller and rescue medication, with data transmitted both to their smartphones and a dashboard accessed by their primary pediatric pulmonary provider.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patient participants that rate the devices as easy to use
Time Frame: 3 months
|
Measuring the feasibility and acceptability of monitoring devices for children ages 6-17 who are at high risk for asthma exacerbation, by having children use the devices and having children/parents answer survey questions regarding their impressions of the product at the beginning of use and after 1.5 and 3 months of use.
|
3 months
|
|
Number of provider participants that rate the devices as easy to use
Time Frame: 3 months
|
Measuring the feasibility and acceptability of monitoring devices for children ages 6-17 who are at high risk for asthma exacerbation, by having children use the devices and having providers answer survey questions regarding their impressions of the product at the beginning of use and after 1.5 and 3 months of use.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patients/parents that exhibit behavioral changes with respect to taking asthma medications as a result of information gained from the monitoring devices.
Time Frame: 3 months
|
How many parents/patients of high risk asthmatic children change behavior regarding how they administer their medications as a result of information that they gained from the devices regarding their adherence to their treatment regimen, gained via phone surveys at 1.5 and 3 months after using the devices.
Patients are surveyed if children are greater than 12 years old.
Parents are surveyed if children are 6-12 years old.
|
3 months
|
|
Number of pediatric pulmonary providers that exhibit behavioral changes with respect to prescribing asthma medications as a result of information gained from the monitoring devices.
Time Frame: 3 months
|
Number of healthcare providers (physicians, nurse practitioners and physician assistants) that feel that their decision-making is affected regarding medication regimens for asthma based on information that they receive on patient adherence from the devices based on survey data gathered at study entry and 3 months after initiation of the devices will be measured.
|
3 months
|
|
Correlation of lung function to percent use of controller medications as measured by adherence devices.
Time Frame: 3 months
|
Evaluate correlation of markers of lung function (spirometry, fractional exhaled nitric oxide (FeNO), with percent adherence as measured by the monitoring devices.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Stanley Szefler, MD, University of Colorado, Denver
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2015
Primary Completion (Actual)
September 1, 2016
Study Completion (Actual)
September 1, 2016
Study Registration Dates
First Submitted
November 24, 2015
First Submitted That Met QC Criteria
November 25, 2015
First Posted (Estimate)
December 1, 2015
Study Record Updates
Last Update Posted (Estimate)
September 16, 2016
Last Update Submitted That Met QC Criteria
September 14, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- 15-0211
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma
-
Meyer Children's Hospital IRCCSRecruitingAsthma in Children | Asthma Acute | Asthma Crisis | Asthma ChildhoodItaly
-
University of PittsburghNational Institute of Environmental Health Sciences (NIEHS)RecruitingAsthma Exacerbation | Childhood Asthma | Air Pollution, Risk Reduction Behaviors | Asthma ControlUnited States
-
Vanderbilt University Medical CenterWithdrawnAsthma in Children | Asthma Attack | Asthma Acute | Acute Asthma Exacerbation | Asthma; StatusUnited States
-
Columbia UniversityChildren's Hospital of Philadelphia; National Heart, Lung, and Blood Institute... and other collaboratorsNot yet recruitingAcute Asthma | Pediatric Asthma | Non-invasive Positive Pressure Ventilation | BiPAPUnited States
-
University of California, San FranciscoCompletedAsthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicUnited States
-
SingHealth PolyclinicsRecruitingAsthma | Asthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicSingapore
-
Johann Wolfgang Goethe University HospitalCompleted
-
Chiesi Slovenija, d.o.o.RecruitingAsthma | Asthma Bronchiale | Asthma PatientsSlovenia
-
Gümüşhane UniversıtyCompletedAsthma | Asthma Chronic | Asthma ControlTurkey (Türkiye)
-
Parc de Salut MarActive, not recruitingAsthma in Children | Persistent Asthma | Asthma ExacerbationSpain
Clinical Trials on Propeller Health Monitoring Device
-
University of Colorado, DenverCompletedAsthmaUnited States
-
David Van SickleFoundation for a Healthy Kentucky; Norton Healthcare Foundation; Owsley Brown...CompletedRespiratory Tract Diseases | Immune System Diseases | Lung Diseases | Hypersensitivity | Hypersensitivity, Immediate | Bronchial Diseases | Lung Diseases, Obstructive | Asthma | Respiratory HypersensitivityUnited States
-
University of ChicagoNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Reciprocal LabsCalifornia HealthCare FoundationCompleted
-
Dr. Deneen VojtaNorthwestern UniversityCompleted
-
The University of Hong KongHaven of Hope Hospital; The Social Innovation and Entrepreneurship Development...CompletedTechnologyHong Kong
-
Chinese PLA General HospitalCompletedSuboptimal Health Status | Metabolic AbnormalityChina
-
International Centre for Diarrhoeal Disease Research...Bill and Melinda Gates Foundation; Salu Design GroupRecruitingHypertension, Pregnancy-Induced | Hypertension in Pregnancy | Hypertension, Essential Hypertension | Hypertension; Pre-EclampsiaBangladesh
-
Children's Hospital of PhiladelphiaUniversity of PennsylvaniaCompleted
-
University of AarhusCompletedChronic Obstructive Pulmonary Disease, COPDDenmark